X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (681) 681
humans (431) 431
benzalkonium chloride (362) 362
animals (284) 284
male (270) 270
female (256) 256
benzalkonium compounds - administration & dosage (252) 252
ophthalmology (184) 184
benzalkonium compounds - pharmacology (152) 152
pharmacology & pharmacy (144) 144
benzalkonium compounds - adverse effects (141) 141
adult (139) 139
middle aged (124) 124
rabbits (103) 103
glaucoma (96) 96
administration, topical (95) 95
ophthalmic solutions (90) 90
benzalkonium compounds - toxicity (88) 88
surface active agents (86) 86
aged (84) 84
in-vitro (76) 76
preservatives (73) 73
preservatives, pharmaceutical - administration & dosage (73) 73
preservatives, pharmaceutical - adverse effects (70) 70
rats (65) 65
benzalkonium compounds - therapeutic use (64) 64
drug combinations (64) 64
toxicity (64) 64
cornea - drug effects (62) 62
time factors (62) 62
abridged index medicus (59) 59
benzalkonium compounds (54) 54
analysis (52) 52
anti-infective agents, local - administration & dosage (52) 52
cornea (52) 52
benzalkonium compounds - chemistry (51) 51
mice (51) 51
dose-response relationship, drug (50) 50
latanoprost (50) 50
treatment outcome (49) 49
disease models, animal (47) 47
eye diseases (47) 47
toxicology (46) 46
travoprost (45) 45
administration, intranasal (44) 44
antihypertensive agents - administration & dosage (44) 44
conjunctiva - drug effects (44) 44
sense organs (43) 43
inflammation (42) 42
preservatives, pharmaceutical - pharmacology (42) 42
preservatives, pharmaceutical - toxicity (42) 42
research article (42) 42
glaucoma - drug therapy (41) 41
double-blind method (40) 40
ocular surface (40) 40
epithelium, corneal - drug effects (39) 39
medicine, research & experimental (39) 39
efficacy (38) 38
ophthalmic drugs (38) 38
cells (37) 37
drugs (37) 37
permeability (37) 37
glaucoma, open-angle - drug therapy (36) 36
in vitro techniques (36) 36
ophthalmic solutions - administration & dosage (36) 36
prospective studies (36) 36
surgery (36) 36
medicine & public health (35) 35
open-angle glaucoma (35) 35
intraocular pressure - drug effects (34) 34
microbiology (34) 34
chlorides (33) 33
eye (33) 33
nasal mucosa - drug effects (33) 33
prevalence (33) 33
research (33) 33
adolescent (32) 32
aged, 80 and over (32) 32
immunology (32) 32
anti-infective agents, local - pharmacology (31) 31
medicine (31) 31
antihypertensive agents - adverse effects (30) 30
health aspects (30) 30
ocular hypertension - drug therapy (30) 30
timolol (30) 30
cloprostenol - analogs & derivatives (29) 29
care and treatment (28) 28
cells, cultured (28) 28
corneal (28) 28
genetic structures (28) 28
ophthalmic solutions - adverse effects (28) 28
safety (28) 28
allergy (27) 27
biotechnology & applied microbiology (27) 27
cytotoxicity (27) 27
drug therapy (27) 27
hypertension (27) 27
otorhinolaryngology (27) 27
bacteria (26) 26
cell survival - drug effects (26) 26
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (726) 726
German (16) 16
French (12) 12
Russian (12) 12
Polish (5) 5
Czech (4) 4
Japanese (4) 4
Chinese (3) 3
Italian (3) 3
Danish (1) 1
Portuguese (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Hospital Infection, ISSN 0195-6701, 2011, Volume 79, Issue 2, pp. 141 - 146
Summary Quaternary ammonium compounds (QACs) are cationic surfactants used as preservatives and environmental disinfectants. Limited data are available... 
Infectious Disease | Biofilm | Antibiotic | Quaternary ammonium compounds | Minimum inhibitory concentrations | Escherichia coli | Hypermutation | INFECTIOUS DISEASES | INFECTIONS | ESCHERICHIA-COLI | BIOCIDE | DEFINITIONS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | RECOMMENDATIONS | PSEUDOMONAS-AERUGINOSA | RESISTANCE | MUTATION FREQUENCIES | AGENTS | BENZALKONIUM CHLORIDE | Prognosis | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Microbial Sensitivity Tests - standards | Aged, 80 and over | Adult | Female | Benzalkonium Compounds - pharmacology | Escherichia coli - growth & development | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Benzalkonium Compounds - therapeutic use | Quaternary Ammonium Compounds - therapeutic use | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | Benzalkonium Compounds - administration & dosage | Treatment Outcome | Escherichia coli - genetics | Escherichia coli - isolation & purification | Quaternary Ammonium Compounds - administration & dosage | Aged | Anti-Bacterial Agents - pharmacology | Mutation | Anti-Bacterial Agents - administration & dosage | Microbial Sensitivity Tests - methods | Quaternary Ammonium Compounds - pharmacology | Index Medicus | Quaternary Ammonium Compounds | Bacteremia | Microbial Sensitivity Tests | Life Sciences | Benzalkonium Compounds | Microbiology and Parasitology | Anti-Bacterial Agents | Biofilms | Escherichia coli Infections
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2009, Volume 147, Issue 4, pp. 725 - 735.e1
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 03/2016, Volume 501, Issue 1-2, pp. 1 - 9
Nanoparticulate drug delivery systems, mucoadhesive polymers and penetration enhancers have been used individually to overcome ocular barriers and increase... 
Nanoparticles | Capric acid | Pluronic F68 | Non-invasive | Sodium taurocholate | Penetration enhancer | Benzalkonium chloride | EDTA | Ocular drug delivery | Sodium glycocholate | PERMEATION ENHANCERS | DRUG-DELIVERY | CHITOSAN NANOPARTICLES | POLYCAPROLACTONE | MICROPARTICLES | GLUTARALDEHYDE | CORNEAL | TRANSPORT | PHARMACOLOGY & PHARMACY | ABSORPTION PROMOTERS | PLGA NANOPARTICLES | Nanoparticles - chemistry | Biological Availability | Coumarins - chemistry | Glycolates - chemistry | Drug Delivery Systems | Surface Properties | Decanoic Acids - chemistry | Eye - drug effects | Taurocholic Acid - chemistry | Glutaral - chemistry | Gelatin - chemistry | Eye - metabolism | Cell Line | Cell Survival - drug effects | Rabbits | Glycolates - administration & dosage | Microscopy, Electron, Scanning | Permeability - drug effects | Nanoparticles - ultrastructure | Benzalkonium Compounds - administration & dosage | Benzalkonium Compounds - chemistry | Decanoic Acids - administration & dosage | Mucins - chemistry | Edetic Acid - administration & dosage | Animals | Edetic Acid - chemistry | Taurocholic Acid - administration & dosage | Polymers - chemistry | Thiazoles - chemistry | Mice | Nanoparticles - administration & dosage | Drugs | Drug delivery systems | Surface active agents | Ophthalmic drugs | Permeability | Saturated fatty acids | Vehicles | Index Medicus
Journal Article
Toxicology, ISSN 0300-483X, 2014, Volume 319, Issue 1, pp. 53 - 62
Abstract Indomethacin (IMC) has been shown to reduce post-operative inflammation and to decrease intraocular irritation after cataract extraction and in... 
Emergency | Eye drops | Indomethacin | Nanoparticle | Transcorneal penetration | Corneal toxicity | PREDNISOLONE ACETATE | BLOOD-AQUEOUS BARRIER | OCULAR DRUG-DELIVERY | CHANG CONJUNCTIVAL CELLS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | INFLAMMATORY RESPONSE | IN-VIVO EVALUATION | EXTRACAPSULAR CATARACT-EXTRACTION | BENZALKONIUM CHLORIDE | PLGA NANOPARTICLES | OPHTHALMIC FORMULATIONS | 2-Hydroxypropyl-beta-cyclodextrin | Nanoparticles - chemistry | Rats, Wistar | Escherichia coli - drug effects | Humans | Ophthalmic Solutions - chemistry | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Male | Indomethacin - administration & dosage | Cornea - drug effects | Zirconium - chemistry | Escherichia coli - growth & development | Wound Healing - drug effects | Cell Line | Ophthalmic Solutions - administration & dosage | Rats | Benzalkonium Compounds - administration & dosage | Benzalkonium Compounds - chemistry | Bacterial Load | Permeability | Cornea - metabolism | Methylcellulose - chemistry | Animals | beta-Cyclodextrins - chemistry | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Indomethacin - chemistry | Mannitol - chemistry | Nanoparticles - administration & dosage | Ophthalmology | T cells | Ophthalmic drugs | Index Medicus | Formulations | Cornea | Eyes | Toxicity | Biocompatibility | Nanostructure | Bioavailability | Beads
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 05/2010, Volume 88, Issue 3, pp. 329 - 336
Purpose: The purpose of this study was to investigate the tolerability and intraocular pressure (IOP) reducing effect of the first preservative-free... 
latanoprost | Taflotan | Preservative-free tafluprost ophthalmic solution | Xalatan | Tolerability | IOP | Patient satisfaction | Quality of life | LATANOPROST | SIGNS | Taflotan (R) | Xalatan (R) latanoprost | PHARMACODYNAMICS | OCULAR SYMPTOMS | patient satisfaction | TAFLUPROST | preservative-free tafluprost ophthalmic solution | tolerability | OPHTHALMOLOGY | quality of life | RECEPTOR AGONIST | Hyperemia - metabolism | Intraocular Pressure - drug effects | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Hyperemia - prevention & control | Conjunctival Diseases - metabolism | Ocular Hypertension - drug therapy | Patient Satisfaction | Prostaglandins F, Synthetic - administration & dosage | Aged, 80 and over | Tonometry, Ocular | Adult | Female | Surveys and Questionnaires | Conjunctival Diseases - chemically induced | HLA-DR Antigens - metabolism | Conjunctival Diseases - prevention & control | Preservatives, Pharmaceutical - adverse effects | Prostaglandins F - administration & dosage | Benzalkonium Compounds - adverse effects | Ophthalmoscopy | Benzalkonium Compounds - administration & dosage | Prostaglandins F, Synthetic - adverse effects | Blepharitis - metabolism | Glaucoma, Open-Angle - drug therapy | Blepharitis - prevention & control | Blepharitis - chemically induced | Exfoliation Syndrome - drug therapy | Mucin 5AC - metabolism | Quality of Life | Hyperemia - chemically induced | Aged | Gonioscopy | Preservatives, Pharmaceutical - administration & dosage | Administration, Topical | Glaucoma | Prostaglandins | Analysis | Pharmacy | Ophthalmic drugs | Mucins | Fluorescein | Ophthalmology | Universities and colleges | Drug therapy | Index Medicus
Journal Article
Journal Article